FY2025 Earnings Forecast for Transcat, Inc. Issued By HC Wainwright (NASDAQ:TRNS)

Transcat, Inc. (NASDAQ:TRNS - Free Report) - Investment analysts at HC Wainwright dropped their FY2025 earnings per share estimates for Transcat in a research note issued to investors on Tuesday, April 16th. HC Wainwright analyst S. Buck now anticipates that the scientific and technical instruments company will earn $2.31 per share for the year, down from their previous forecast of $2.41. HC Wainwright has a "Buy" rating and a $124.00 price objective on the stock. The consensus estimate for Transcat's current full-year earnings is $1.33 per share.

Transcat (NASDAQ:TRNS - Get Free Report) last announced its earnings results on Monday, January 29th. The scientific and technical instruments company reported $0.38 EPS for the quarter, beating analysts' consensus estimates of $0.35 by $0.03. The company had revenue of $65.17 million during the quarter, compared to the consensus estimate of $63.36 million. Transcat had a return on equity of 9.32% and a net margin of 4.16%.

Other research analysts have also recently issued reports about the company. Oppenheimer reissued an "outperform" rating and issued a $125.00 price target (up from $120.00) on shares of Transcat in a report on Thursday. TheStreet raised Transcat from a "c+" rating to a "b" rating in a report on Wednesday, January 31st.

Transcat Stock Performance

Shares of NASDAQ:TRNS traded up $0.54 during mid-day trading on Thursday, reaching $105.25. 39,155 shares of the company traded hands, compared to its average volume of 37,969. The company's 50 day moving average price is $108.70 and its 200-day moving average price is $101.88. The firm has a market cap of $929.36 million, a PE ratio of 81.36 and a beta of 0.59. The company has a debt-to-equity ratio of 0.01, a current ratio of 3.37 and a quick ratio of 2.81. Transcat has a 52 week low of $74.89 and a 52 week high of $115.41.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the company. Conestoga Capital Advisors LLC raised its holdings in shares of Transcat by 0.6% during the fourth quarter. Conestoga Capital Advisors LLC now owns 762,861 shares of the scientific and technical instruments company's stock valued at $83,404,000 after buying an additional 4,805 shares during the last quarter. Fred Alger Management LLC raised its holdings in shares of Transcat by 6.1% during the first quarter. Fred Alger Management LLC now owns 727,225 shares of the scientific and technical instruments company's stock valued at $65,007,000 after buying an additional 41,563 shares during the last quarter. Wasatch Advisors LP raised its holdings in shares of Transcat by 13.3% during the fourth quarter. Wasatch Advisors LP now owns 701,099 shares of the scientific and technical instruments company's stock valued at $76,651,000 after buying an additional 82,458 shares during the last quarter. BlackRock Inc. raised its holdings in shares of Transcat by 8.1% during the second quarter. BlackRock Inc. now owns 494,947 shares of the scientific and technical instruments company's stock valued at $42,224,000 after buying an additional 37,225 shares during the last quarter. Finally, Vanguard Group Inc. raised its holdings in Transcat by 12.3% during the fourth quarter. Vanguard Group Inc. now owns 477,799 shares of the scientific and technical instruments company's stock worth $52,238,000 after purchasing an additional 52,421 shares in the last quarter. 98.34% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Transcat

In other news, Director Charles P. Hadeed sold 700 shares of the business's stock in a transaction dated Monday, February 12th. The stock was sold at an average price of $113.00, for a total value of $79,100.00. Following the completion of the sale, the director now directly owns 22,678 shares of the company's stock, valued at approximately $2,562,614. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, Director Charles P. Hadeed sold 700 shares of the stock in a transaction that occurred on Monday, February 12th. The stock was sold at an average price of $113.00, for a total transaction of $79,100.00. Following the completion of the transaction, the director now directly owns 22,678 shares of the company's stock, valued at approximately $2,562,614. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, CEO Lee D. Rudow sold 2,373 shares of the stock in a transaction on Saturday, March 30th. The shares were sold at an average price of $111.43, for a total value of $264,423.39. Following the sale, the chief executive officer now owns 103,688 shares in the company, valued at approximately $11,553,953.84. The disclosure for this sale can be found here. In the last ninety days, insiders sold 8,073 shares of company stock valued at $900,023. 4.20% of the stock is currently owned by corporate insiders.

Transcat Company Profile

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.